‘Research here is world class’: son of Steve Jobs looks to invest in UK cancer care After death of his father, Reed Jobs is keen for his $1bn venture capital fund Yosemite to make a difference The Guardian - UK · May 16
Millions of children with rare diseases set to benefit from faster diagnosis and better treatments A new platform is being developed by Great Ormond Street Hospital and LifeArc in collaboration with the Children’s Hospital Alliance The Independent UK · Feb 12
The finger prick blood test that could revolutionise Alzheimer’s diagnosis The test aims to pick up three proteins known to be associated with Alzheimer’s The Independent UK · Jan 19
Man paralysed and needs 24-hour care after catching mild flu as toddler Timothy Bingham was two years old when he had a mild flu-like illness which left him unable to walk The Independent UK · Jul 16, 2025
Scientists unlock secret behind rare disease where flu can cause paralysis One family said that the discovery offers hope. Evening Standard · Jul 16, 2025
First new non-opioid painkiller approved in the US for decades – here’s how it works A new non-opioid painkiller, suzetrigine, has just been approved by the US drug regulator, the FDA. It is the first non-opioid painkiller the agency has approved in over two decades. The Conversation · Feb 5, 2025
Imagine getting life-saving drugs to sick people without relying on big pharma? We may have found a way An NHS trust’s attempts to bring a crucial drug to market itself is hopeful news for patients, says Dr Catriona Crombie of the medical charity LifeArc The Guardian - UK · May 16, 2024
Great Ormond Street hoping to license gene therapy for ‘bubble baby’ syndrome Hospital to take unprecedented step after drug firm pulled out despite successful trial of treatment The Guardian - UK · May 14, 2024
AI-powered app could be ‘revolutionary’ for cystic fibrosis patients The latest version of Breathe RM uses an algorithm that can predict when patients are going to get ill up to 10 days in advance. The Independent UK · Dec 27, 2023